£40 million boost for UK Dementia Institute at UCL

The UK Dementia Research Institute(UK DRI), which is headquarted at UCL, will receive £40m of UK Government funding via the Medical Research Council, helping ensure its pioneering research is conducted in first-class facilities. Launched in 2016, the UK DRI, has received significant investment from three founding partners: Medical Research Council; Alzheimer's Society; and Alzheimer's Research UK. It employs world-leading academics, whose work is helping benefit the lives of millions of people living with dementia now and in the future. The £40 million funding, announced today will be used to help develop a new £250m building at UCL, which will host the central hub of UK DRI, alongside the university's world-class Institute of Neurology. UCL President & Provost Professor Michael Arthur said: "Understanding the causes of dementia and discovering potential treatments, is a huge priority for UCL, and we were delighted to be chosen as the hub university for the UK Dementia Research Institute in 2016. "The UK DRI is bringing together world leading researchers and cutting edge technology, and constructing a high class bespoke facility is critical to the Institute's future success. "We are delighted with the Government's £40m investment, which combined with the substantial financial commitments of UCL and our key partners, will help create a world-class facility alongside the Institute of Neurology, helping shape the future of dementia research for decades to come." The new building will be part of large redevelopment at the Eastman Dental Hospital, Gray's Inn Road, London, which UCLH has agreed to sell to UCL.